Dr. Nikunj Jain
Co-Founder and HOD - Nuclear Medicine ,MBBS, DRM, DNB, FEBNM, FANMB, Dip. CBNC
Lung cancer remains one of the leading causes of cancer-related deaths worldwide, largely because it is often diagnosed at an advanced stage. Early detection plays a crucial role in improving survival rates. One of the most promising tools for this is the Low-Dose CT scan (LDCT), which can detect lung cancer before symptoms appear. Unlike a standard CT, LDCT uses significantly less radiation, making it safer for routine screening among high-risk individuals. In cities like Delhi NCR and across India, awareness of LDCT is growing, encouraging more people to opt for timely screening.
A Low-Dose CT scan is a specialized form of computed tomography designed to use lower doses of radiation compared to a standard chest CT scan. It creates detailed cross-sectional images of the lungs, allowing radiologists to detect small nodules or masses that may suggest early-stage lung cancer.
By combining safety with accuracy, LDCT offers an effective method to detect lung cancer early, when treatment options are more effective and survival rates are higher.
Most lung cancers develop silently, with symptoms like persistent cough or chest pain often appearing only in advanced stages. At that point, treatment becomes more challenging, and survival rates drop. LDCT screening addresses this gap by:
Multiple large studies, including the National Lung Screening Trial (NLST) in the US, have shown that LDCT screening can reduce lung cancer deaths by about 20% in people at high risk.
LDCT screening isn’t recommended for everyone. It is most beneficial for individuals at higher risk, including:
It’s always best to discuss personal risk factors with a healthcare provider to determine if LDCT is appropriate.
The LDCT procedure is simple, quick, and usually does not require special preparation:
Since the radiation dose is lower than a standard CT scan, the test can be safely repeated annually for those at continued risk.
LDCT has emerged as an essential tool in preventive healthcare for high-risk groups. Some key benefits include:
While LDCT is highly beneficial, it is important to understand its limitations:
Discussing these risks with a healthcare provider helps patients make an informed decision about screening.
If the LDCT scan detects a nodule or abnormal area, the next steps usually include:
Many small nodules turn out to be harmless; regular follow-up is key to distinguishing benign from malignant findings.
Historically, chest X-rays were used for lung screening but proved ineffective in reducing deaths from lung cancer. LDCT has clear advantages:
As a result, LDCT is now the recommended standard for lung cancer screening in eligible individuals.
LDCT is generally not recommended for:
For these groups, the risks of screening may outweigh the benefits.
In India, especially in metro cities like Delhi, Mumbai, and Bengaluru, LDCT scans are now offered by many leading hospitals and diagnostic centers. The cost typically ranges from ₹4,000 to ₹10,000 depending on the center and technology used.
Annual screening costs should be weighed against the potential benefit of early detection, which can save lives and reduce the need for more expensive treatments later.
Low-Dose CT scan for lung cancer screening has revolutionized the approach to early detection among high-risk populations. By offering detailed imaging with much less radiation, LDCT makes it possible to identify cancer before symptoms appear, when treatment outcomes are often better. While it is not for everyone, for smokers and those with a family history, it can be life-saving. As awareness and availability grow in India, especially in cities like Delhi NCR, more people can benefit from this powerful tool against lung cancer.
A Low-Dose CT scan uses reduced radiation to create detailed images of the lungs, mainly for screening high-risk individuals.
Adults aged 50–80 with a significant smoking history or other risk factors should consider annual screening.
No, it is a non-invasive and painless procedure.
No, but it helps detect cancer early, improving the chances of successful treatment.
Typically once a year, as long as the person remains at high risk.
Your doctor may order follow-up scans, PET-CT, or a biopsy to determine if it is cancerous.
Routine LDCT screening usually does not require contrast.
LDCT uses about 75–90% less radiation.
Yes, especially in major cities like Delhi, Mumbai, and Bengaluru.
It is usually recommended only for those at higher risk, but a doctor can advise based on individual history.
Book tests, view reports, and manage your health records on the go. Experience convenient healthcare with Molecular Diagnostics and Therapy.